U.S. Court Backs U.S. FDA Over Wyeth's Plea To Protect Zosyn From Orchid's Generic Copies

MUMBAI - In a blow to Wyeth in its attempts to protect anti-bacterial combination injection Zosyn (piperacillin/tazobactum), the U.S. District Court of Columbia dismised a plea for a temporary restraining order against the U.S. FDA's decision to approve generic copies of the drug from India's Orchid Chemicals